Filing Details
- Accession Number:
- 0001288123-17-000040
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-14 16:14:27
- Reporting Period:
- 2017-10-09
- Accepted Time:
- 2017-12-14 16:14:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1098972 | Agenus Inc | AGEN | Biological Products, (No Disgnostic Substances) (2836) | 061562417 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1437152 | Karen Valentine | C/O Antigenics Inc. 3 Forbes Rd Lexington MA 02421 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-10-09 | 24,824 | $3.59 | 109,879 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2017-12-12 | 8,358 | $3.46 | 101,521 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents settlement of restricted shares awarded on July 1, 2015.
- Represents sales of shares sold solely to cover Federal , state and local tax on withholding requirements on the restricted shares settled and were sold at prices ranging between $3.495 and $3.44 per share.
Billionaire Hedge Funds
